Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY

Details for Australian Patent Application No. 2005311099 (hide)

Owner Domantis Limited

Inventors Tomlinson, Ian M.; Holt, Lucy J.; Jespers, Laurent S.; Holmes, Steve

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005311099

PCT Pub. Number WO2006/059106

Priority 60/632,361 02.12.04 US; 0511019.2 31.05.05 GB

Filing date 30 November 2005

Wipo publication date 8 June 2006

Acceptance publication date 2 February 2012

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/059106 Priority application(s): WO2006/059106

2 February 2012 Application Accepted

  Published as AU-B-2005311099

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311101-Anti-IL-IRI single domain antibodies and therapeutic uses

2005311098-Non-cytotoxic protein conjugates